510(k) Report

510(k) · Cleared

Cleared

Axsym Cortisol Assay

K033731510(k) TraditionalCleared Feb 20, 200484-day reviewClass II21 CFR 862.1205

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Fujirebio Diagnostics,Inc. · JFT Fluorometric, Cortisol

Cleared on Feb 20, 2004 after an 84-day review. The FDA summary names its predicate without a number. 2 later devices descend from it.

Decided
Feb 20, 2004
Review
84 days
Class
Class II
Product code
JFT
Recalls
None
Predicates
0

2 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2006: 1 descendant cleared2025: 1 descendant cleared200020052010201520202025
  1. This deviceK033731 Axsym Cortisol AssayFujirebio Diagnostics,Inc. · 2004
  2. Descendant · cites it directly · 1 of its ownK062204 Architect Cortisol AssaySeradyn, Inc. · 2006
  3. Descendant · 2 generations on · 0 of its ownK242505 Elecsys Cortisol IIIRoche Diagnostics · 2025

Most influential descendants

Showing 2 of 2 · See all
  • K062204Architect Cortisol AssaySeradyn, Inc. · 2006 · cites it directly1descendant
  • K242505Elecsys Cortisol IIIRoche Diagnostics · 2025 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K033731Axsym Cortisol AssayFujirebio Diagnostics,Inc.2004—
+1K062204Architect Cortisol AssaySeradyn, Inc.2006—
+2K242505Elecsys Cortisol IIIRoche Diagnostics2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
202510
FIG. 1 — Lineage of K033731, 2004–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JFT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JFT device

  1. #1 K242505 Elecsys Cortisol IIIscore 10.0 · 2 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Beckman Access® Cortisol assay
Named without a submission number
—

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K062204Architect Cortisol AssaySeradyn, Inc.20061

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K062204 (Seradyn, Inc., 2006) has gone furthest, with 1 descendant of its own.

How does its category compare?

All JFT devices

JFT Fluorometric, Cortisol: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JFT

1in 2025

2015: 12016: 12019: 12025: 1
2007high 1 (2015) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JFT

Too few JFT 510(k)s in any year since 2007 to give a median.

Recalls per year · JFT

1in 2012

2012: 1
2007high 1 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JFT

9in 2025

2011: 12012: 162013: 62016: 22017: 42018: 32019: 62020: 42021: 22022: 22023: 92024: 52025: 9
2007high 16 (2012) · low 0 (2007)2025

MAUDE reports naming product code JFT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—01
20120—116
20130—06
20140—00
20151—00
20161—02
20170—04
20180—03
20191—06
20200—04
20210—02
20220—02
20230—09
20240—05
20251—09
20260—0—

What is it indicated for?

The AxSYM® Cortisol assay is a Fluorescence Polarization Immunoassay (FPIA) for the quantitative measurement of Cortisol in human serum, plasma or urine on the AxSYM® System to aid in the diagnosis and treatment of adrenal disorders.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K033731: Axsym Cortisol Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K033731

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026